⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024Open Access

Supplementary Figure S2 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA

Shifeng Lian Chenyu Lu Fugui Li Xia Yu Limei Ai Biaohua Wu Xueyi Gong Wenjing Zhou Xuejun Liang Jiyun Zhan Yong Yuan Fang Fang Zhiwei Liu Mingfang Ji Zongli Zheng

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S2. Genome-wide copy number profile change in seven HCC patients before and after transarterial chemoembolization (TACE). The colors green, blue, dark red, and red correspond to copy number deletion, neutral, gain, and amplification, respectively

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lian et al. (2024) studied this question.

synapsesocial.com/papers/68e62195b6db6435875b3707 https://doi.org/10.1158/1078-0432.26134474

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA2024
2Supplementary Figure S1 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA2024
3Supplementary Figure S1 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA2024
4Supplementary Figure S4 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA2024
5Supplementary Figure S4 from Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA2024